免疫系统
提吉特
生物
免疫检查点
基因表达谱
免疫疗法
癌症研究
免疫学
质量细胞仪
肿瘤微环境
抗原
干扰素
间质细胞
转录组
多路复用
拷贝数变化
生物标志物发现
ARID1A型
计算生物学
生物标志物
CD8型
基因组不稳定性
作者
Anastasiia Korosteleva,Josephine Sophie Reschke,Dawei Yi,Silke Marhenke,Jinbo Zhao,Valery Volk,Tanja Reineke‐Plaaß,Simon Peters,Charlotte Hoffmann,Doan Duy Hai Tran,Christoph Gerdes,Melanie Bathon,Walter Kölch,Friedrich Feuerhake,Vadim Zhernovkov,Anna Lena Saborowski,Arndt Vogel
标识
DOI:10.1097/hc9.0000000000001052
摘要
BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is characterized by marked molecular and microenvironmental heterogeneity and moderate response to immunotherapy. We aimed to define the genomic and spatial determinants of immune checkpoint activity in iCCA and their association with clinical outcome. METHODS: We performed integrated transcriptomic, DNA panel sequencing, and multiplex immunohistochemistry analyses in a cohort of 144 patients with iCCA. Tumors were classified according to STIM-defined microenvironmental subtypes. Spatially resolved immune profiling was conducted across the tumor core, stroma, invasive margin, and adjacent liver. Immune checkpoint expression, cellular proximity, and clinical outcome were analyzed using Cox regression and Kaplan-Meier methods. TIGIThigh tumors were further characterized by differential gene expression and pathway enrichment analyses.ResultsSTIM classification stratified tumors into inflamed (47%) and non-inflamed (53%) subtypes with distinct survival outcomes and genomic profiles. Recurrent alterations in CDKN2A/B, TP53, MTAP, and BAP1 showed subtype-specific enrichment and prognostic relevance. Spatial immune profiling revealed compartment-specific distributions of T cells and immune checkpoints, with predominance of TIGIT and PD-1 expression in stromal and marginal regions. Most tumor-infiltrating T cells lacked inhibitory receptor expression, while co-expression of multiple checkpoints was uncommon. TIGIThigh tumors displayed coordinated activation of immune effector, antigen presentation, and interferon signaling pathways, alongside enrichment of distinct genomic alterations, defining an immune-activated molecular subtype. CONCLUSION: Integrated genomic and spatial immune profiling reveals pronounced context-dependent heterogeneity of immune checkpoint regulation in iCCA. TIGIT delineates an immune-activated subtype with distinct molecular features, providing a potential biomarker framework for patient stratification and rational immunotherapeutic targeting.
科研通智能强力驱动
Strongly Powered by AbleSci AI